Clinical Dialogue: Addressing the Burden of HPV Disease
This activity will address issues related to the burden of HPV disease and the current recommendations from the Advisory Committee on Immunization Practices (ACIP) from the Centers for Disease Control and Prevention. HPV is a common virus, with nearly 1 in 4 (~80 million) people in the U.S. who are currently infected, and an estimated 14 million who are newly infected each year. HPV causes cervical, vaginal, vulvar, anal, oropharynx and penile cancers, as well as genital warts. HPV immunization offers significant opportunities to diminish these potentially deadly cancers and sequelae resulting from HPV infection.
At the conclusion of this activity, the PA should be better able to:
- Discuss the prevalence of HPV infection, the types of cancers it causes and the impact of HPV vaccination in the U.S.
- State the ACIP recommendations for HPV vaccination in children aged 9-14 and persons aged 15-26.
- State the recently licensed expanded indication for use in persons aged 27-45
- Identify perceived barriers by both health care providers and patients to HPV vaccination.
- Apply strategies to overcome perceived barriers to HPV vaccination in the pediatric, adolescent and/or adult clinic setting.
eCase Challenge also available.